Software
Communications
Lighting
Electrical/Electronics
RF & Microwave Electronics
Semiconductors & ICs
Energy
Photonics/Optics
Imaging
Motion Control
Robotics, Automation & Control
Test & Measurement
Sensors/Data Acquisition
Manufacturing & Prototyping
Materials & Coatings
Mechanical & Fluid Systems
Propulsion
Transportation
Automotive
Current Issue
Magazine Archives
Andrew Corselli
A new study led by Dr. Lin Su of Queen Mary University of London, published in the Journal of the American Chemical Society, describes a new integrated solar reactor in which engineered Escherichia coli (E. coli) are grown directly inside the same liquid that converts CO₂ into a usable energy source using sunlight.
In the future, this technology may be used to make environmentally clean chemicals, plastics, or even microbial protein.
The device combines an organic solar cell, a semiconductor electrode, two enzymes, and an engineered bacterium, and converts CO₂ and water into living biomass, reproducing the stages of natural photosynthesis without any plant, alga, or photosynthetic microbes.
Here is an exclusive Tech Briefs interview, edited for length and clarity, with Su.
Tech Briefs: What was the biggest technical challenge you faced while developing this integrated solar reactor?
Su: The greatest hurdle was realizing autonomous, solar-driven CO2-to-biomass conversion in a single reactor, which required us to bridge the fundamental differences between abiotic and biotic environments. Specifically, we had to overcome three physicochemical compatibility barriers:
Tech Briefs: The article I read says, “This opens the way to swapping in engineered strains that produce target chemicals beyond biomass.” What could this mean for the future of the industry?
Su: For the industry, this represents a major step toward a “formate bioeconomy” that drastically reduces our reliance on traditional sugar feedstocks. We are not looking to replace plants, but rather to access chemistries that plants cannot perform, such as manufacturing industrial precursors, polymers, or speciality molecules without burning fossil fuels. Furthermore, because our system uses engineered bacteria that fix dissolved CO2 into biomass and use formate as an energy vector, it actively helps with carbon emissions. This approach could eventually open the way to supplying food and chemicals in a manner that uses far less land and water, helping to dampen the climate challenges we currently face.
Tech Briefs: Doc, you’re quoted in the article I read as saying, “While it is at an early stage, with the yields still small and the reactor running for hours rather than weeks, it is very promising.” My question is: Do you have any set plans for further research/work/etc.? If not, what are your next steps?
Su: Yes, we have several clear avenues for our next steps:
Enhancing Growth and Balancing Oxygen: Currently, our oxygen and nutrient management relies on operational workarounds rather than a clean chemical solution. We observed that hypoxic conditions severely inhibit bacterial growth and cause the bacteria to shift their metabolism toward producing acetate instead of biomass. We need to optimise this balance.
System Scalability: Because the current reactor runs for hours rather than weeks, improving long-term cyclic stability and scaling the system are top priorities.
Engineering for Valuable Compounds: While we focused on generating biomass in this study, we want to leverage our platform for targeted chemical synthesis. Interestingly, the “hypoxic switch” we discovered, where oxygen limitation channels fixed carbon into acetate, suggests a powerful strategy. By applying metabolic engineering, we could deliberately control this switch to channel fixed carbon into a diverse portfolio of valuable bioproducts.
Tech Briefs: Is there anything you’d like to add that I didn’t touch upon?
Mimicking ‘Plant Power’ Through Artificial Photosynthesis
Humidity-Resistant Hydrogen Sensor Can Improve Safety for Large-Scale Clean Energy
Su: I think the backstory of how this collaboration began is quite serendipitous. It started in May 2023 when Prof. Erwin Reisner visited the Weizmann Institute to give a lecture on his group’s artificial leaves. Prof. Ron Milo showed Erwin his lab’s engineered autotrophic E. coli, and they immediately realised the chemistry and biology could fit together perfectly. Ron even gave Erwin a signed copy of his book with an inscription, hoping they would join forces. Just two months later, Eliya Milshtein sent the first plate of the engineered bacteria to our lab in Cambridge. At the same time, Dr Celine Yeung was wrapping up her PhD project integrating organic photovoltaics with formate-producing enzymes. We had a robust, ready-to-go chemical platform, making it the perfect time to integrate it with the microbes.
Tech Briefs: Do you have any advice for researchers aiming to bring their ideas to fruition?
Su: My biggest piece of advice is to actively reach out to people and keep an open mind for suggestions. This project came together like a jigsaw puzzle shaped by years of disparate research, from materials chemistry to enzyme purification to synthetic biology. We could only achieve this through a cross-disciplinary approach, pairing isolated enzymes and semiconductors with engineered microbes. Don’t be afraid to cross geographical boundaries and scientific disciplines to find the right collaborators.
A Proof‑of‑Concept Quantum Battery
Ultrasound Wristband Precisely Tracks Hand Movements in Real Time
Reciprocal Energy: A New Model for Grid-Friendly Data Centers
Groundbreaking Study in Light Control Opens Door to New Technological…
NASA’s Space Computing Breakthrough Powers Future Missions
How Much Do You Know About Aircraft Safety?
Scaling SDV Development with Virtualization
Why Your Motor Behaves Badly: See BLDC Control Signals, Power, and EMI in One Shot
From Spec to Scale: High-Precision Grinding Strategies for Tight-Tolerance Repeatability
High-Speed Connectivity for Next Generation Aerospace & Defense Systems
Electronics Digital Twins: From Concept to Scalable Platform
Architecting the Future: Why Systems Engineering is the Backbone of SDVs
About
Medical Design Briefs
Mobility Engineering Technology
Service Status
By submitting your personal information, you agree that SAE Media Group and carefully selected industry sponsors of this content may contact you and that you have read and agree to the Privacy Policy.
You may reach us at privacy@saemediagroup.com.
You may unsubscribe at any time.
Subscriber Services
Feedback
Contact Us
Site Map
Advertise
Privacy Policy
Cookie Usage
© 2009-2026 SAE Media Group
